Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Arthritis Rheumatol. 2018 Feb 6;70(3):417–426. doi: 10.1002/art.40392

Table 2.

Cumulative incidence of ESRD and mortality by sex

Outcome Year 1 Year 2 Year 3 Year 4 Year 5
ESRD*
  Males 7.1 (4.4–10.8) 9.6 (6.9–15.1) 15.9 (11.1–21.6) 18.3 (12.9–24.4) 22.3 (16.0–29.3)#
  Females 5.9 (4.9–6.9) 10.4 (9.1–11.8) 13.9 (12.8–15.5) 17.8 (15.9–19.7) 21.2 (19.0–23.5)
Mortality
  Males 2.8 (1.3–5.5) 4.7 (2.3–8.2) 7.4 (4.2–12.0) 8.4 (4.8–13.4) 9.4 (5.4–14.9)##
  Females 3.7 (3.0–4.7) 5.8 (4.8–6.8) 7.0 (5.9–8.3) 8.0 (6.8–9.4) 9.8 (8.3–11.5)
*

ESRD analysis accounts for the competing risk of death

#

4.77 years,

##

4.5 years